Sagimet Biosciences Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/94c2d36c-03fb-443c-a726-89df6e945996/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-56.9M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-026140 |
| FY 2024 | $-54.5M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002747 |
| FY 2023 | $-30.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003812 |
| FY 2022 | $-31.1M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-003812 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).